Stay updated with breaking news from Chief Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- LivAway Suites®, the rapidly expanding economy extended-stay hotel brand boasting a developer-centric platform, tapped a crucial new addition...
Stratos Wealth Advisors (Stratos), a part of Stratos Wealth Holdings announced it has successfully recruited a senior team of wealth managers from RBC Wealth Management who will establish the firm's first Northern Nevada office. The team will use...
MENLO PARK, Calif., April 01, 2024 -- Corcept Therapeutics Incorporated , a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic,...
MENLO PARK, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced completion of enrollment in GRADIENT, a Phase 3 trial of its proprietary selective cortisol modulator relacorilant in patients with Cushing’s syndrome (hypercortisolis
D-Wave Quantum Inc. reports earnings inline with expectations. Reported EPS is $-0.1 EPS, expectations were $-0.1.